Rachel Hodan completed her Genetic Counseling master’s degree in 2012, started working for Stanford Health Care in 2013, and subsequently developed the GI Cancer Genetics Clinic which she has co-led since 2018. She is a Clinical Associate Professor at Stanford University, an instructor for the Stanford master’s program in Human Genetics and Genetic Counseling and a co-director of the cancer genetics training course. Rachel has been Stanford’s representative to the NCCN inherited colorectal cancer risk guidelines committee since 2020. She is a longtime hereditary cancer support group facilitator at Bay Area Cancer Connections (BACC) in collaboration with Facing our Risk of Cancer Empowered (FORCE). She is an active member and former research committee chair of CGA-IGC and currently serves on the CGA-IGC meeting planning committee. She is passionate about improving cascade testing rates for hereditary cancer syndromes and in 2021, she began work as a collaborator on an NIH-funded randomized clinical trial studying novel approaches to increase cascade testing for inherited cancer pathogenic variants.
